Adoram Therapeutics
Swiss · Founded 2022
About Adoram Therapeutics
Adoram Therapeutics is a company that uses the benefits of allosteric biochemistry to develop novel therapies for patients suffering from immune-based illnesses or solid malignancies.
Company Facts
- Founded: 2022
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.4M
- Funding stage: Seed
- Last round: Grant (May 2025)
- Website: https://adoram.ch
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/adoram-therapeutics-47598 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.